146 related articles for article (PubMed ID: 25141241)
1. Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials.
Peura DA; Traxler B; Kocun C; Lind T
Postgrad Med; 2014 Jul; 126(4):33-41. PubMed ID: 25141241
[TBL] [Abstract][Full Text] [Related]
2. A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
Peura D; Le Moigne A; Pollack C; Nagy P; Lind T
Postgrad Med; 2016 Aug; 128(6):577-83. PubMed ID: 27331882
[TBL] [Abstract][Full Text] [Related]
3. Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.
Peura DA; Le Moigne A; Wassel H; Pollack C
BMC Gastroenterol; 2018 May; 18(1):69. PubMed ID: 29788903
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg.
Katz PO; Le Moigne A; Pollack C
Clin Ther; 2017 May; 39(5):960-970. PubMed ID: 28431766
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.
Kushner PR; Snoddy AM; Gilderman L; Peura DA
Postgrad Med; 2009 Jul; 121(4):67-75. PubMed ID: 19641272
[TBL] [Abstract][Full Text] [Related]
6. Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment.
Miner PB; Johnson DA; Katz PO; Li J; Gatoulis SC; Pollack C
Adv Ther; 2018 Nov; 35(11):2024-2040. PubMed ID: 30255418
[TBL] [Abstract][Full Text] [Related]
7. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
Johnson DA; Le Moigne A; Hugo V; Nagy P
Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the symptom response to esomeprazole 20 mg over days 1-4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials.
Peura D; Le Moigne A; Wassel H; Pollack C
BMJ Open Gastroenterol; 2019; 6(1):e000278. PubMed ID: 31297231
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn.
Allgood LD; Grender JM; Shaw MJ; Peura DA
J Clin Pharm Ther; 2005 Apr; 30(2):105-12. PubMed ID: 15811162
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.
Laine L; Katz PO; Johnson DA; Ibegbu I; Goldstein MJ; Chou C; Rossiter G; Lu Y
Aliment Pharmacol Ther; 2011 Jan; 33(2):203-12. PubMed ID: 21114792
[TBL] [Abstract][Full Text] [Related]
12. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.
Fass R; Sontag SJ; Traxler B; Sostek M
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):50-6. PubMed ID: 16431305
[TBL] [Abstract][Full Text] [Related]
14. Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis.
Katz PO; Castell DO; Levine D
Aliment Pharmacol Ther; 2003 Nov; 18(9):875-82. PubMed ID: 14616151
[TBL] [Abstract][Full Text] [Related]
15. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial.
Ostovaneh MR; Saeidi B; Hajifathalian K; Farrokhi-Khajeh-Pasha Y; Fotouhi A; Mirbagheri SS; Emami H; Barzin G; Mirbagheri SA
Neurogastroenterol Motil; 2014 May; 26(5):670-8. PubMed ID: 24533896
[TBL] [Abstract][Full Text] [Related]
16. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
[TBL] [Abstract][Full Text] [Related]
17. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
Castell DO; Kahrilas PJ; Richter JE; Vakil NB; Johnson DA; Zuckerman S; Skammer W; Levine JG
Am J Gastroenterol; 2002 Mar; 97(3):575-83. PubMed ID: 11922549
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects.
Peura DA; Riff DS; Snoddy AM; Fennerty MB
Aliment Pharmacol Ther; 2009 Sep; 30(5):459-68. PubMed ID: 19523177
[TBL] [Abstract][Full Text] [Related]
20. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
Vakil NB; Shaker R; Johnson DA; Kovacs T; Baerg RD; Hwang C; D'Amico D; Hamelin B
Aliment Pharmacol Ther; 2001 Jul; 15(7):927-35. PubMed ID: 11421866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
